MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature

Azumagawa K, Nomura S, Shigeri Y, Jones LS, Sato DK, Nakashima I, Kashiwagi M, Tanabe T, Shimakawa S, Nakajima H, Tamai H (2016) Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy. Brain Dev 38:690–693

PubMed  Article  Google Scholar 

Badrawi N, Kumar N, Albastaki U (2021) Post COVID-19 vaccination neuromyelitis optica spectrum disorder: case report and MRI findings. Radiol Case Rep 16:3864–3867

PubMed  PubMed Central  Article  Google Scholar 

Butler M, Tamborska A, Wood GK, Ellul M, Thomas RH, Galea I, Pett S, Singh B, Solomon T, Pollak TA, Michael BD, Nicholson TR (2021) Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder. J Neurol Neurosurg Psychiatry 92:1144–1151

PubMed  Article  Google Scholar 

Chen S, Fan XR, He S, Zhang JW, Li SJ (2021) Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19. Neurol Sci 42:3537–3539

PubMed  PubMed Central  Article  Google Scholar 

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, Ciron J, Collongues N, Brassat D, Cotton F, Papeix C, Durand-Dubief F, Laplaud D, Deschamps R, Cohen M, Biotti D, Ayrignac X, Tilikete C, Thouvenot E, Brochet B, Dulau C, Moreau T, Tourbah A, Lebranchu P, Michel L, Lebrun-Frenay C, Montcuquet A, Mathey G, Debouverie M, Pelletier J, Labauge P, Derache N, Coustans M, Rollot F, De Seze J, Vukusic S, Marignier R, OFSEP and NOMADMUS Study Group (2018) Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology 90:e1858–e1869

CAS  PubMed  Article  Google Scholar 

Dams L, Kraemer M, Becker J (2021) MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination. Mult Scler. https://doi.org/10.1177/13524585211057512

Article  PubMed  Google Scholar 

Escola JK, Deuschl C, Junker A, Dusse F, Pul R, Kleinschnitz C, Kohrmann M, Frank B (2022) MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report. Ther Adv Neurol Disord 15:17562864211070684

PubMed  PubMed Central  Article  Google Scholar 

European Centre for Disease Prevention and Control (2022) Data on COVID-19 vaccination in the EU/EEA. https://www.ecdc.europa.eu/en/publications-data/data-covid-19-vaccination-eu-eea. Accessed 20 May 2022

Francis A, Palace J, Fugger L (2022) MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19. Lancet Neurol 21:217–218

CAS  PubMed  Article  Google Scholar 

Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S (2021) Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 384:2092–2101

CAS  PubMed  Article  Google Scholar 

Hemmer B et al (2021) Diagnosis and therapy of multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-IgG-associated diseases, S2k guideline. In: Deutsche Gesellschaft für Neurologie (Ed.) Guidelines for diagnosis and therapy in neurology. www.dgn.org/leitlinien (retrieved 07.04.2022)

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hummert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement—frequency, presentation and outcome. J Neuroinflamm 13:281

Article  CAS  Google Scholar 

Jarius S, Lechner C, Wendel EM, Baumann M, Breu M, Schimmel M, Karenfort M, Marina AD, Merkenschlager A, Thiels C, Blaschek A, Salandin M, Leiz S, Leypoldt F, Pschibul A, Hackenberg A, Hahn A, Syrbe S, Strautmanis J, Hausler M, Krieg P, Eisenkolbl A, Stoffels J, Eckenweiler M, Ayzenberg I, Haas J, Hoftberger R, Kleiter I, Korporal-Kuhnke M, Ringelstein M, Ruprecht K, Siebert N, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, Rostasy K, in cooperation with the Bsg, the Neuromyelitis optica Study G (2020) Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients. J Neuroinflammation 17:262

CAS  PubMed  PubMed Central  Article  Google Scholar 

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kumpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflamm 15:134

CAS  Article  Google Scholar 

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kumpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B (2018) MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. Nervenarzt 89:1388–1399

CAS  PubMed  Article  Google Scholar 

Jarius S, Paul F, Franciotta D, Ruprecht K, Ringelstein M, Bergamaschi R, Rommer P, Kleiter I, Stich O, Reuss R, Rauer S, Zettl UK, Wandinger KP, Melms A, Aktas O, Kristoferitsch W, Wildemann B (2011) Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J Neurol Sci 306:82–90

CAS  PubMed  Article  Google Scholar 

Jarius S, Paul F, Martins da Silva A, Leite MI, Waters P, Littleton E, Franciotta D, Palace J, Zipp F, Vincent A (2007) Neuromyelitis optica and longitudinally extensive transverse myelitis following thymectomy for myasthenia gravis. Mult Scler 13:P534

Article  Google Scholar 

Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B (2020) Neuromyelitis optica. Nat Rev Dis Primers 6:85

PubMed  Article  Google Scholar 

Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hummert MW, Ringelstein M, Rommer PS, Ayzenberg I, Ruprecht K, Klotz L, Asgari N, Zrzavy T, Hoftberger R, Tobia R, Buttmann M, Fechner K, Schanda K, Weber M, Asseyer S, Haas J, Lechner C, Kleiter I, Aktas O, Trebst C, Rostasy K, Reindl M, Kumpfel T, Paul F, Wildemann B, in cooperation with the Neuromyelitis Optica Study G (2020) Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: results from 163 lumbar punctures in 100 adult patients. J Neuroinflamm 17:261

CAS  Article  Google Scholar 

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflamm 13:280

Article  CAS  Google Scholar 

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hummert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M (2016) MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. J Neuroinflamm 13:279

Article  CAS  Google Scholar 

Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Then Bergh F, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Munch C, Winkelmann A, Zettl UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F (2012) Contrasting disease patterns in seropositive and seronegative Neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflamm 9:14

CAS  Article  Google Scholar 

Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, Tackley G, Hamid S, Sheard A, Reynolds G, Chandratre S, Hemingway C, Jacob A, Vincent A, Leite MI, Waters P, Palace J (2017) Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140:3128–3138

PubMed  Article  Google Scholar 

Kania K, Ambrosius W, Tokarz Kupczyk E, Kozubski W (2021) Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2. Ann Clin Transl Neurol 8:2000–2003

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kumar N, Graven K, Joseph NI, Johnson J, Fulton S, Hostoffer R, Abboud H (2020) Case report: postvaccination anti-myelin oligodendrocyte glycoprotein Neuromyelitis optica spectrum disorder: a case report and literature review of postvaccination demyelination. Int J MS Care 22:85–90

PubMed  PubMed Central  Article  Google Scholar 

Lai QL, Zhang YX, Cai MT, Zheng Y, Qiao S, Fang GL, Shen CH (2021) Efficacy and safety of immunosuppressive therapy in myelin oligodendrocyte glycoprotein antibody-associated disease: a systematic review and meta-analysis. Ther Adv Neurol Disord 14:17562864211054156

CAS  PubMed  PubMed Central  Article  Google Scholar 

Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J (2012) Myasthenia gravis and Neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. Neurology 78:1601–1607

CAS  PubMed  PubMed Central  Article  Google Scholar 

Loos J, Pfeuffer S, Pape K, Ruck T, Luessi F, Spreer A, Zipp F, Meuth SG, Bittner S (2020) MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation. J Neurol 267:1632–1642

CAS  PubMed  PubMed Central  Article  Google Scholar 

Marignier R, Hacohen Y, Cobo-Calvo A, Probstel AK, Aktas O, Alexopoulos H, Amato MP, Asgari N, Banwell B, Bennett J, Brilot F, Capobianco M, Chitnis T, Ciccarelli O, Deiva K, De Seze J, Fujihara K, Jacob A, Kim HJ, Kleiter I, Lassmann H, Leite MI, Linington C, Meinl E, Palace J, Paul F, Petzold A, Pittock S, Reindl M, Sato DK, Selmaj K, Siva A, Stankoff B, Tintore M, Traboulsee A, Waters P, Waubant E, Weinshenker B, Derfuss T, Vukusic S, Hemmer B (2021) Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol 20:762–772

CAS  PubMed  Article  Google Scholar 

Matsumoto Y, Ohyama A, Kubota T, Ikeda K, Kaneko K, Takai Y, Warita H, Takahashi T, Misu T, Aoki M (2022) MOG antibody-associated disorders following SARS-CoV-2 vaccination: a case report and literature review. Front Neurol 13:845755

PubMed  PubMed Central  Article  Google Scholar 

Minsterio della Salute (2022) Report vaccini anti COVID-19. https://www.governo.it/it/cscovid19/report-vaccini. Accessed 20 May 2022

Miyamoto K, Koh J, Takahashi M, Niwa M, Ito H (2022) A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination. Neurol Sci 43(6):3513–3514

PubMed  PubMed Central  Article  Google Scholar 

Mori M, Kawaguchi N, Uzawa A, Nemoto Y, Masuda S, Kuwabara S (2012) Seroconversion of anti-aquaporin-4 antibody in NMO spectrum disorder: a case report. J Neurol 259:980–981

PubMed  Article  Google Scholar 

Mumoli L, Vescio V, Pirritano D, Russo E, Bosco D (2022) ADEM anti-MOG antibody-positive after SARS-CoV2 vaccination. Neurol Sci 43:763–766

留言 (0)

沒有登入
gif